E-LIB Suche - Ergebnisse für: Floquet, A.

1

19P Long term sexual disorders among rare ovarian cancer su..:

Dubot, C. ; Joly Lobbedez, F. ; Ray Coquard, I.L....
ESMO Open. 8 (2023) 1 - p. 101040 , 2023

Link: https://doi.org/10.1016/..

2

13O Impact of surgery and chemotherapy in ovarian sex cord-..:

Hanvic, B. ; Lecuru, F. ; Vanacker, H....
ESMO Open. 8 (2023) 1 - p. 101034 , 2023

Link: https://doi.org/10.1016/..

3

A single-arm multicentre phase II trial of doxorubicin in c..:

Pautier, P. ; Floquet, A. ; Chevreau, C....
ESMO Open. 6 (2021) 4 - p. 100209 , 2021

Link: https://doi.org/10.1016/..

4

Menopausal symptoms in epithelial ovarian cancer survivors:..:

Gernier, F. ; Gompel, A. ; Rousset-Jablonski, C....
Gynecologic Oncology. 163 (2021) 3 - p. 598-604 , 2021

Link: https://doi.org/10.1016/..

5

Flexor tendon rupture after volar plating of distal radius ..:

Floquet, A. ; Druart, T. ; Lavantes, P...
Hand Surgery and Rehabilitation. 40 (2021) 5 - p. 535-546 , 2021

Link: https://doi.org/10.1016/..

6

The French national network dedicated to rare gynecological..:

Lenck, C. ; Chopin, N. ; Gouy, S....
Gynecologic Oncology. 157 (2020) 1 - p. 78-84 , 2020

Link: https://doi.org/10.1016/..

7

Arcagen: Molecular profiling of rare cancer patients – anal..:

Morfouace, M. ; Ray-Coquard, I. ; Girard, N....
European Journal of Cancer. 138 (2020) - p. S32 , 2020

Link: https://doi.org/10.1016/..

8

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F. ; Floquet, A. ; Hardy-Bessard, A.C....
Gynecologic Oncology. 158 (2020) 3 - p. 666-672 , 2020

Link: https://doi.org/10.1016/..

9

Prognostic value of PET-CT scan on survival outcomes of adv..:

Petousis, S. ; Cazeau, A.L. ; Crombe, A....
Gynecologic Oncology. 159 (2020) - p. 343 , 2020

Link: https://doi.org/10.1016/..

10

Overall survival results of AGO-OVAR16: A phase 3 study of ..:

Vergote, I. ; du Bois, A. ; Floquet, A....
Gynecologic Oncology. 155 (2019) 2 - p. 186-191 , 2019

Link: https://doi.org/10.1016/..

11

Ganglions rétropéritonéaux hypermétaboliques en TEP–TDM FDG..:

Roch, A. ; Courbier, A. ; Kind, M....
Médecine Nucléaire. 43 (2019) 2 - p. 189 , 2019

Link: https://doi.org/10.1016/..

12

Phase II study of the PI3K inhibitor BKM120 in patients wit..:

Heudel, P-E ; Fabbro, M ; Roemer-Becuwe, C...
British Journal of Cancer. 116 (2017) 3 - p. 303-309 , 2017

Link: https://doi.org/10.1038/..

13

Prise en charge primaire des cancers de l'endomètre : recom..:

Querleu, D. ; Darai, E. ; Lecuru, F....
Gynécologie Obstétrique Fertilité & Sénologie. 45 (2017) 12 - p. 715-725 , 2017

Link: https://doi.org/10.1016/..

14

Health State Utilities for Persistent, Recurrent or Metasta..:

Chevalier, J ; Lambert, J ; Floquet, A...
Value in Health. 19 (2016) 7 - p. A744 , 2016

Link: https://doi.org/10.1016/..

15

Secondary mutations in RAD51C and RAD51D are associated wit..:

Lin, K. ; Tinker, A.V. ; Kondrashova, O....
European Journal of Cancer. 69 (2016) - p. S13 , 2016

Link: https://doi.org/10.1016/..